Go to Top

Metabolic Markets accepted for publication again!

Last year M2 did considerable work in gout.  In partnership with our friends at Symphony Health, M2's Aaron Davis's abstract has been accepted to the American College of Rheumatology's annual conference.  The title: "Assessing The Increasing Costs To Manage Patients With Gout By State"  Gout is a surprisingly costly disease state that goes unrecognized / untreated, which demands more expensive interventions later in the course of the disease, costs that could have been avoided with improved screening and treatment.  In our work, we see a geographic variation in treatment patterns and opportunities for targeted primary care and patient education to bend the cost curve down.

More to come on this topic!  Now we need to finish the poster!